Second Temporary Extension Of COVID-19 Telemedicine Flexibilities For Prescription Of Controlled Medications
On October 10, 2023, the U.S. Department of Health and Human Services published this temporary rule regarding the second temporary extension of COVID-19 telemedicine flexibilities for prescription of controlled medications. As of November 11, 2023, the end of the effective period for the temporary rule published at 88 Federal Rule 30037 on May 10, 2023, is extended from November 11, 2024, to December 31, 2024. This rule is effective November 11, 2023 . . .